CANMAB INJECTION 440MG

CANMAB INJECTION 440MG is generally given along with the chemotherapy medication such as paclitaxel or docetaxel or platinum compounds. Sometimes, it is also given with hormonal agents for those patients with elevated hormonal status.

Yes, CANMAB INJECTION 440MG can damage the heart muscles. Hence to prevent the worsening of symptoms, it is advised to do heart check up every 3 months and continue till 2-5 years after the treatment completion.

No, since it tends to pass into breast milk, it is unsafe to breastfeed. Hence, It is advised not to breastfeed for a minimum of 7 months after the treatment with CANMAB INJECTION 440MG.

No, it is unsafe to consume CANMAB INJECTION 440MG while you are pregnant as this medicine can cause harm to the baby by reducing the amount of amniotic fluid, the fluid surrounding the womb. It can also cause organ developmental issues such as poor lung development when consumed during pregnancy. If you are planning for pregnancy, it is advised to discuss birth control methods as this medicine may impair your fertility.

It is important to tell your doctor about all the medicines you are currently taking, including prescription and over-the-counter medicines, vitamins, and herbal supplements, before starting treatment with CANMAB INJECTION 440MG. Your doctor will check for potential interactions.

Inform your doctor if you have a history of allergic reactions, lung disorder, or breathing problems. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Your heart function should be monitored regularly during the treatment.

TRASTUZUMAB is the active molecule used to make CANMAB INJECTION 440MG. It is a type of targeted therapy that works by attaching to a specific protein called HER2 found on some cancer cells.

CANMAB INJECTION 440MG (containing TRASTUZUMAB) works by targeting and blocking the HER2 protein, which helps cancer cells grow and divide. By blocking this protein, the medicine can slow or stop the growth of cancer.

CANMAB INJECTION 440MG is prescribed for certain types of cancer, primarily breast cancer and gastric cancer, that have too much of the HER2 protein (HER2-positive cancer).